SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-07-117162
Filing Date
2007-05-17
Accepted
2007-05-16 21:29:43
Documents
2
Period of Report
2007-05-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 10860
2 LETTER FROM L. PATRICK GAGE, CHAIRMAN OF THE BOARD OF PDL BIOPHARMA, INC. dex991.htm EX-99.1 9364
  Complete submission text file 0001193125-07-117162.txt   21797
Mailing Address 34801 CAMPUS DR FREMONT CA 94555
Business Address 34801 CAMPUS DR FREMONT CA 94555 5105741400
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 07859401
SIC: 2836 Biological Products, (No Diagnostic Substances)